 3. Laboratory evidence of myopathy with at least one of the following: an elevated serum CK or aldolase level, myositis-specific antibody, electromyography EMG demonstrating myopathic features e.g., muscle membrane instability, myopathic units, or early recruitment, or an abnormal skeletal muscle MRI showing diffuse or patchy edema within the muscles. 